|
May 1
|
Bausch + Lomb Q1 Net Loss Widens, But Revenue Higher; Raises 2024 Revenue Growth Guidance
|
|
Apr 29
|
All You Need to Know About Bausch (BHC) Rating Upgrade to Buy
|
|
Apr 25
|
Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
|
|
Apr 24
|
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 23
|
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
|
|
Apr 20
|
10 Best Healthcare Stocks to Buy Under $20
|
|
Apr 11
|
Bausch Health to Announce First-Quarter 2024 Results on May 2
|
|
Apr 11
|
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
|
|
Apr 11
|
Bausch wins US appeal to block Alvogen generic of diarrhea drug
|
|
Apr 11
|
Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?
|
|
Apr 11
|
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
|
|
Apr 8
|
CANADA STOCKS-TSX ends flat as gold stocks drop, mood cautious ahead of rate decision
|
|
Apr 8
|
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
|
|
Apr 8
|
BLCO vs. AVTR: Which Stock Is the Better Value Option?
|
|
Apr 5
|
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
|
|
Apr 3
|
/C O R R E C T I O N from Source -- Canadian Investment Regulatory Organization (CIRO) - Halts/Resumptions/
|
|
Apr 3
|
Here's Why Bausch Health (BHC) is a Strong Momentum Stock
|
|
Apr 3
|
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
|
|
Apr 2
|
Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
|
|
Apr 1
|
Breakeven Is Near for Bausch Health Companies Inc. (NYSE:BHC)
|